NCT00835276View on ClinicalTrials.gov

Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

Fexofenadine 180 mg tablets

1 x 180 mg

DRUG

ALLEGRA® 180 mg tablets

1 x 180 mg

Trial Locations (1)

58102

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835276 - Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter